Sylvia Boj received her PhD from the University of Barcelona and trained as postdoctoral EMBO fellow in the laboratory of Prof. Hans Clevers, where she established an in vitro organoid model for human pancreatic cancers.
In 2013, she joined HUB as one of the founding scientist and worked as a group leader for Cystic Fibrosis and Cancer Organoid programs. In 2016, she was appointed Scientific Director at HUB. Since 2020, she holds the position of Chief Scientific Officer.
